Cencora, Inc. Declares Quarterly Dividend of $0.55 (NYSE:COR)

Key Points

• Cencora, Inc. declared a quarterly dividend of $0.55 per share, payable on September 3rd to stockholders of record by August 15th, representing an annualized dividend yield of 0.8%.
• The company reported a 4.00 EPS for the last quarter, exceeding analysts' expectations, with a revenue of $80.66 billion, reflecting an 8.7% increase year-over-year.
• Shares of Cencora traded down 3.2%, reaching $282.89, while the stock has a market cap of $54.83 billion and a price-to-earnings ratio of 32.87.

Cencora, Inc. (NYSE:COR - Get Free Report) declared a quarterly dividend on Wednesday, August 6th, RTT News reports. Shareholders of record on Friday, August 15th will be given a dividend of 0.55 per share on Wednesday, September 3rd. This represents a c) annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, August 15th.

Cencora has a payout ratio of 12.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cencora to earn $16.88 per share next year, which means the company should continue to be able to cover its $2.20 annual dividend with an expected future payout ratio of 13.0%.

Cencora Price Performance

Cencora stock traded up $7.06 during mid-day trading on Friday, hitting $285.46. 1,106,201 shares of the company were exchanged, compared to its average volume of 1,099,116. The company has a debt-to-equity ratio of 3.64, a current ratio of 0.90 and a quick ratio of 0.52. The business's 50 day simple moving average is $292.51 and its two-hundred day simple moving average is $277.58. The company has a market capitalization of $55.33 billion, a P/E ratio of 29.37, a PEG ratio of 1.36 and a beta of 0.58. Cencora has a 12-month low of $218.65 and a 12-month high of $309.35.

Cencora (NYSE:COR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $4.00 earnings per share for the quarter, topping the consensus estimate of $3.79 by $0.21. The company had revenue of $80.66 billion during the quarter, compared to the consensus estimate of $80.34 billion. Cencora had a return on equity of 267.36% and a net margin of 0.60%. Cencora's revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $3.34 earnings per share. Analysts forecast that Cencora will post 15.37 earnings per share for the current fiscal year.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.